Estimated read time: 1-2 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
NEW YORK (AP) — The Latest on a federal appeals court upholding the securities fraud conviction against former drug company CEO Martin Shkreli (all times local):
___
12:10 p.m.
Martin Shkreli's lawyer has expressed disappointment after a federal appeals court upheld the securities fraud conviction against the former drug company CEO.
Benjamin Brafman issued a statement after the decision Thursday in New York.
Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran.
Before his arrest, Shkreli was best known for buying the rights to a lifesaving drug at another company in 2014 and raising the price from $13.50 to $750 per pill.
He also gained notoriety for attacking critics on social media under the moniker "Pharma Bro." He was barred from Twitter for posts about a female journalist.
___
10:50 a.m.
A federal appeals court has upheld the securities fraud conviction against former drug company CEO Martin Shkreli.
Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran.
A message requesting comment was emailed to Shkreli's legal team Thursday.
Before his arrest, Shkreli was best known for buying the rights to a lifesaving drug at another company in 2014 and raising the price from $13.50 to $750 per pill.
He also gained notoriety for attacking critics on social media under the moniker "Pharma Bro." He was barred from Twitter for posts about a female journalist.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
